Resultados de la búsqueda 91-100 of 4946 for pharmacogenetics

  1. Mayo Clinic Cancer Physician Update - September 2025

    Page 1.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  3. Mayo Clinic Physician Update - March 2025

    Page 1.

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

  5. Clinical Update - December 2008 - MC2024-1208

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  6. Mayo Clinic Cancer Physician Update - March 2025

    Page 1.

  7. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  10. Mayo Clinic Cardiovascular Physician Update - July 2025

    Page 1.